Delivery Order SPE2DB20D2104-SPE2DB25FMJUD

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,964.90 firm fixed-price delivery order is for the supply of 4567050123 NORETHINDRONE 5 MG TABLET 90S, with a performance period through January 28, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,105.83 firm fixed-price contract provides the DLA with 4,557,601,070 units of the medication Norethindrone 5 mg tablets. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,989.22 firm-fixed-price delivery order is for the supply of 90 tablets of Norethindrone 5 mg, a generic medication. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. This award is associated with a larger indefinite delivery contract (IDC) held by...
This federal contract award, valued at $4,839.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4564689236 NORETHINDRONE 5 MG TABLET 90S. The award is not associated with a set-aside program and has an ultimate completion date of May 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,326.35, is a Firm Fixed Price Delivery Order for the supply of 4567202005 Norethindrone 5 mg Tablets in 90-count packages. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,099.00 Firm Fixed Price delivery order contract is for the supply of 4,559,459,281 units of the pharmaceutical product Norethindrone 5 mg Tablets, in 50-count packages. The contract has an ultimate completion date of December 28, 2022. No set-aside designation was used for this open competition award....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,750.86 firm fixed-price delivery order contract is for the supply of 4566785121 - NORETHINDRONE 5MG 90S, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025 and was awarded on December 23, 2024. There was no set-aside designation for this award....
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,167.75 firm fixed-price delivery order is for the supply of 4566407491 - Norethindrone 5 mg Tablets in 50-count bottles. The award is not associated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,888.16 firm fixed-price delivery order is for the supply of 90-count tablets of the medication Norethindrone 5 mg. The contract, which has an ultimate completion date of December 19, 2024, is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,373.79 firm fixed-price delivery order is for the supply of 4556089076 norethindrone 5 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMJUD
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,026.09 firm fixed-price delivery order contract is for the supply of 4567379202 NORETHINDRONE 5 MG TABLET 90S, with a period of performance through February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 5/27/25, 9:44 AM